1. AHRO : Austin Health Research Online
  2. Austin Health research
  3. Journal articles
Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/21124
Full metadata record
DC FieldValueLanguage
dc.contributor.authorTrubiano, Jason-
dc.contributor.authorSlavin, Monica A-
dc.contributor.authorThursky, Karin A-
dc.contributor.authorGrayson, M Lindsay-
dc.contributor.authorPhillips, Elizabeth J-
dc.date2019-06-13-
dc.date.accessioned2019-07-08T05:20:49Z-
dc.date.available2019-07-08T05:20:49Z-
dc.date.issued2019-09-
dc.identifier.citationThe Journal of Allergy and Clinical Immunology. In Practice 2019; 7(7): 2151-2153en
dc.identifier.urihttps://ahro.austin.org.au/austinjspui/handle/1/21124-
dc.description.abstractAntibiotic allergies are reported in up to 1 in 4 immunocompromised hosts with significant impacts on antibiotic utilization and patient outcomes. Health services programs focused on de-labeling beta-lactam and sulfonamide allergy labels should be a standard of care in immunocompromised hosts.en
dc.language.isoeng-
dc.subjectAntibiotic allergyen
dc.subjectAntibiotic allergy testingen
dc.subjectPenicillin allergyen
dc.subjectPenicillin allergy testingen
dc.titleBeta-Lactam and Sulfonamide Allergy Testing Should Be a Standard of Care in Immunocompromised Host.en
dc.typeJournal Articleen
dc.identifier.journaltitleThe Journal of Allergy and Clinical Immunology. In Practiceen
dc.identifier.affiliationInstitute for Immunology and Infectious Diseases, Murdoch University, Murdoch, WA, Australiaen
dc.identifier.affiliationNational Centre for Antimicrobial Stewardship, Royal Melbourne Hospital, Parkville, Victoria, Australiaen
dc.identifier.affiliationDepartment of Infectious Diseases, Austin Health, Heidelberg, Victoria, Australiaen
dc.identifier.affiliationDepartment of Infectious Diseases, Peter MacCallum Cancer Centre, Parkville, Victoria, Australiaen
dc.identifier.affiliationDepartment of Medicine, Austin Health, The University of Melbourne, Heidelberg, Victoria, Australiaen
dc.identifier.affiliationThe National Centre for Infections in Cancer, Peter MacCallum Cancer Centre, Parkville, Victoria, Australiaen
dc.identifier.affiliationDepartment of Infectious Diseases, Vanderbilt University Medical Centre, Nashville, Tenn, USAen
dc.identifier.doi10.1016/j.jaip.2019.05.051en
dc.type.contentTexten
dc.identifier.orcid0000-0002-5111-6367en
dc.identifier.pubmedid31253580-
dc.type.austinJournal Article-
local.name.researcherGrayson, M Lindsay-
item.grantfulltextnone-
item.openairetypeJournal Article-
item.fulltextNo Fulltext-
item.languageiso639-1en-
item.cerifentitytypePublications-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
crisitem.author.deptInfectious Diseases-
crisitem.author.deptMedicine (University of Melbourne)-
crisitem.author.deptCentre for Antibiotic Allergy and Research-
crisitem.author.deptInfectious Diseases-
Appears in Collections:Journal articles
Show simple item record

Page view(s)

38
checked on Oct 22, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.